LACTOPRES:Study on the Effect of Dairy Peptides on Blood Pressure in Untreated Hypertensive Subjects.

Phase 2

Completed

• Conditions: Hypertension

• Registration Number: NCT00167869
• Lead Sponsor: Wageningen University

Brief Summary

Hypertension is an increasingly important medical and public health issue. Literature suggests that there may be a role for dairy foods in the prevention and treatment of hypertension. Recently, it has been suggested that several peptides in milk proteins could have blood pressure lowering properties. LACTOPRES is a randomised, double-blind parallel trial to assess the blood pressure effect of an increased intake of dairy peptides in humans.

Detailed Description

Not available

Study Timeline

• Study Start: 2004-06
• Primary Completion: 2005-06
• Study Completion: 2005-06
• Study First Submitted: 2005-09-12
• Study First Submitted QC: 2005-09-12
• Study First Posted: 2005-09-14
• Status Verified: 2008-05
• Last Update Submitted: 2008-05-23
• Last Update Posted: 2008-05-29

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 135

Inclusion Criteria

• systolic blood pressure >= 140 mmHg
• BMI between 18 and 32 kg/m2
• apparently healthy

Exclusion Criteria

• antihypertensive medication
• medically prescribed or slimming diet
• lactating, pregnant
• irregular pulse

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Blood pressure

Trial Locations

Locations (1)

Wageningen University, Division of Human Nutrition; 🇳🇱 Wageningen, Netherlands